Publications by Professor Andrew Pearson - ePrints

Browsing publications by Professor Andrew Pearson.

Newcastle Authors	Title	Year
Professor Andrew Pearson Professor Roderick Skinner	A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence	2021
Professor Andrew Pearson Dr Simon Bomken	ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children	2019
Professor Andrew Pearson Dr Pamela Kearns Professor Hermann Josef Vormoor	Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective	2017
Professor Andrew Pearson Professor Hermann Josef Vormoor	From class waivers to precision medicine in paediatric oncology	2017
Nermine Basta Dr Gail Halliday Richard Feltbower Dr Nicholas Bown Professor Andrew Pearson et al.	Factors associated with recurrence and survival length following relapse in patients with neuroblastoma	2016
Professor Andrew Pearson Dr Quentin Campbell Hewson Professor Alan Boddy Melanie Griffin	A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study	2015
Professor Deborah Tweddle Professor Andrew Pearson	MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance	2014
Professor Gareth Veal Julie Errington Sophie Rowbotham Nicola Illingworth Dr Ghada Malik et al.	Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma	2013
Nermine Basta Dr Gail Halliday Richard Feltbower Dr Nicholas Bown Professor Andrew Pearson et al.	Factors associated with recurrence and length of survival following relapse in patients with neuroblastoma: a pilot study	2012
Melanie Griffin Professor Alan Boddy Professor Andrew Pearson	Adaptation and Validation of the Plasma Inhibitory Activity (PIA) Assay to Detect Inhibition of Aurora, ABL and FLT3 kinases by AT9283 In Children and Adolescents with Leukaemia	2010
Professor Roderick Skinner Annie Parry Lisa Price Mike Cole Professor Andrew Pearson et al.	Glomerular Toxicity Persists 10 Years After Ifosfamide Treatment in Childhood and Is Not Predictable by Age or Dose	2010
Dr Jane Carr-Wilkinson Kieran O'Toole Angela Baker Julian Board Mike Cole et al.	High frequency of p53/MDM2/p14^ARFpathway abnormalities in relapsed neuroblastoma	2010
Professor Gareth Veal Julie Errington Professor Andrew Pearson Professor Alan Boddy	Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients	2010
Professor Roderick Skinner Annie Parry Lisa Price Mike Cole Professor Andrew Pearson et al.	Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors	2009
Dr Maria Lastowska Dr Mauro Santibanez Koref Ilka Wappler Dr Heiko Peters Dr Andrew Hall et al.	Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data	2007
Professor Andrew Pearson	Lung metastases in neuroblastoma at initial diagnosis: A report from the international neuroblastoma risk group project	2007
Dr Lindi Chen Professor Archibald Malcolm Dr Katrina Wood Mike Cole Professor Andrew Pearson et al.	p53 is nuclear and functional in both undifferentiated and differentiated neuroblastoma	2007
Olabisi Onilude Dr Meryl Lusher Dr Janet Lindsey Professor Andrew Pearson Professor David Ellison et al.	APC and CTNNB1 mutations are rare in sporadic ependymomas	2006
Dr Jane Carr-Wilkinson Dr Emma Bell Professor Andrew Pearson Professor John Lunec Professor Deborah Tweddle et al.	Increased frequency of aberrations in the p53/MDM2/p14ARF pathway in neuroblastoma cell lines established at relapse	2006
Bojidar Goranov Dr Quentin Campbell Hewson Professor Andrew Pearson Dr Chris Redfern	Overexpression of RARγ increases death of SH-SY5Y neuroblastoma cells in response to retinoic acid but not fenretinide [3]	2006
Mike Cole Professor Alan Boddy Dr Pamela Kearns Lisa Price Annie Parry et al.	Potential clinical impact of taking multiple blood samples for research studies in paediatric oncology: How much do we really know?	2006
Professor David Ellison Olabisi Onilude Dr Janet Lindsey Dr Meryl Lusher Professor Andrew Pearson et al.	β-catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee	2005
Dr Jayne Lamont Professor Deborah Tweddle Professor Andrew Pearson Professor Steven Clifford Professor David Ellison et al.	A 7-year-old boy with midline cerebellar mass	2005
Dr Jane Renwick Professor Alan Boddy Dr Chris Redfern Professor Andrew Pearson Professor Gareth Veal et al.	Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells	2005
Professor John Lunec Julian Board Professor Andrew Pearson	No evidence for correlation of DDX1 gene amplification with improved survival probability in patients with MYCN-amplified neuroblastomas [15]	2005
Annie Parry Dr Michael Tilby Professor Dianne Ford Emerita Professor Suzanne Cholerton Professor Andrew Pearson et al.	Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer	2005
Professor Gareth Veal Mike Cole Julie Errington Annie Parry Dr Juliet Hale et al.	Pharmacokinetics of dactinomycin in a pediatric patient population: A United Kingdom Children's Cancer Study Group study	2005
Professor David Ellison Professor Andrew Pearson Professor Steven Clifford Dr Jayne Lamont Charles McManamy et al.	Combined histopathological and molecular cytogenetic stratification defines a high-risk subset of patients with medulloblastoma - A United Kingdom Children's Cancer Group Study	2004
Dr Jayne Lamont Charles McManamy Professor Andrew Pearson Professor Steven Clifford Professor David Ellison et al.	Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients	2004
Professor Andrew Pearson Professor Alan Boddy	Cyclophosphamide Metabolism in Children with Non-Hodgkin's Lymphoma	2004
Mike Cole Annie Parry Dr Michael Keir Professor Andrew Pearson Professor Alan Boddy et al.	Estimation of glomerular filtration rate in paediatric cancer patients using ⁵¹CR-EDTA population pharmacokinetics	2004
Professor Penny Lovat Professor Andrew Pearson Dr Andrew Hall Dr Chris Redfern	Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide	2004
Dr Xiaohong Lu Professor Herbie Newell Professor Andrew Pearson Professor John Lunec	Identification of MYCN transcriptional activity inhibitors yields compounds which preferentially inhibit the growth of neuroblastoma cells	2004
Professor Steven Clifford Dr Janet Lindsey Dr Meryl Lusher Dr Richard Gilbertson Professor Andrew Pearson et al.	Identification of tumour suppressor genes in childhood medulloblastoma by promoter hypermethylation profiling	2004
Dr Janet Lindsey Dr Meryl Lusher Jennifer Anderton Professor Simon Bailey Dr Richard Gilbertson et al.	Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling	2004
Dr Tibor Nyari Professor Andrew Pearson Professor Deborah Tweddle Julian Board	Large cell neuroblastoma: A distinct phenotype of neuroblastoma with aggressive clinical behavior	2004
Dr Maria Lastowska Professor Andrew Pearson Dr Michael Jackson	Regions Syntenic to Human 17q Are Gained in Mouse and Rat Neuroblastoma	2004
Professor David Ellison Charles McManamy Professor Andrew Pearson Professor Steven Clifford	The clinical utility of stratifying medulloblastomas (MBs) by a combination of detailed histopathologic evaluation and molecular cytogenetic analysis	2004
Nidal Boulos Professor Andrew Pearson Dr Michael Tilby Professor John Lunec	1p deleted neuroblastoma cells differentiate following chromosome 1 reintroduction	2003
Professor Gareth Veal Julie Errington Julieann Sludden Melanie Griffin Annie Parry et al.	Determination of anti-cancer drug actinomycin D in human plasma by liquid chromatography-mass spectrometry	2003
Julie Errington Professor Gareth Veal Julieann Sludden Melanie Griffin Professor Andrew Pearson et al.	Determination of the anti-cancer drug actinomycin D in human plasma by liquid chromatography-mass spectrometry	2003
Tyrone John Professor Andrew Pearson Professor Alan Calvert Dr Michael Tilby	Determination, by ICP-MS, of background and BBR 3464 induced levels of platinum bound to DNA isolated from blood cells: A comparison of the sensitivity of the Perkin Elmer Sciex Elan 6000 and the thermofinnigan Neptune instruments	2003
Professor Deborah Tweddle Julian Board Professor Andrew Pearson Professor John Lunec	Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[131I]iodobenzylguanidine by neuroblastoma tumors	2003
Dr Debbie Scott Joanna Elsden Professor Andrew Pearson Professor John Lunec	Genes co-amplified with MYCN in neuroblastoma: Silent passengers or co-determinants of phenotype?	2003
Professor Penny Lovat Professor Andrew Pearson Dr Chris Redfern	Growth and DNA Damage-Inducible Transcription Factor 153 Mediates Apoptosis in Response to Fenretinide but Not Synergy between Fenretinide and Chemotherapeutic Drugs in Neuroblastoma	2003
Dr Janet Lindsey Dr Meryl Lusher Professor Andrew Pearson Professor David Ellison Professor Steven Clifford et al.	Identification of tumour suppressor genes in childhood medulloblastoma by promoter hypermethylation profiling	2003
Dr Debbie Scott Dr Janet Lindsey Dr Meryl Lusher Professor Andrew Pearson Professor David Ellison et al.	Identification of tumour suppressor loci on chromosome 10q in medulloblastoma	2003
Professor Penny Lovat Professor Andrew Pearson Dr Chris Redfern	Induction of GADD153 and Bak: Novel molecular targets of fenretinide-induced apoptosis of neuroblastoma	2003
Professor Penny Lovat Professor Andrew Pearson Dr Chris Redfern	Mechanisms of free-radical induction in relation to fenretinide-induced apoptosis of neuroblastoma	2003
Dr Jayne Lamont Charles McManamy Professor Andrew Pearson Professor Steven Clifford Professor David Ellison et al.	Molecular cytogenetic analysis of a cohort of medulloblastomas	2003
Charles McManamy Dr Jayne Lamont Mike Cole Professor Andrew Pearson Professor Steven Clifford et al.	Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas	2003
Professor Gareth Veal Julie Errington Professor Andrew Pearson Professor Alan Boddy	Poster Presentation: Oxidative metabolism of 13-cis-retinoic acid in children with neuroblastoma	2003
Dr Nicholas Bown Julie Freeman-Edward Professor John Lunec Dr Katia Mazzocco Steven O'Neill et al.	Quality assessment of genetic markers used for therapy stratification	2003
Dr Jane Carr-Wilkinson Julian Board Dr Katrina Wood Professor Andrew Pearson Professor John Lunec et al.	Selection for p53 mutant cells by chemotherapy in high-risk neuroblastoma	2003
Dr Xiaohong Lu Professor Andrew Pearson Professor John Lunec	The MYCN oncoprotein as a drug development target	2003
Dr Debbie Scott Julian Board Dr Xiaohong Lu Professor Andrew Pearson Dr Rebecca Kenyon et al.	The neuroblastoma amplified gene, NAG: Genomic structure and characterisation of the 7.3 kb transcript predominantly expressed in neuroblastoma	2003
Professor Deborah Tweddle Professor Andrew Pearson Professor John Lunec	The p53 pathway and its inactivation in neuroblastoma	2003
Dr Birju Rana Professor Gareth Veal Professor Andrew Pearson Dr Chris Redfern	Retinoid X receptors and retinoid response in neuroblastoma cells	2002
Dr Meryl Lusher Dr Janet Lindsey Professor Andrew Pearson Professor David Ellison Professor Steven Clifford et al.	Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development	2002
Dr Maria Lastowska Simon Cotterill Natalie Bown Professor John Lunec Professor Tom Strachan et al.	Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors	2002
Nidal Boulos Professor Andrew Pearson Dr Michael Tilby Professor John Lunec	Functional complementation analysis of chromosome 1 in neuroblastoma	2002
Professor Penny Lovat Dr Quentin Campbell Hewson Professor Andrew Pearson Dr Chris Redfern	GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma	2002
Professor Gareth Veal Julie Errington Dr Chris Redfern Professor Andrew Pearson Professor Alan Boddy et al.	Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells	2002
Professor John Lunec Julian Board Professor Andrew Pearson	Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay	2002
Dr Quentin Campbell Hewson Professor Penny Lovat Professor Andrew Pearson Dr Chris Redfern	Retinoid signalling and gene expression in neuroblastoma cells: RXR agonist and antagonist effects on CRABP-II and RARβ expression	2002
Dr Birju Rana Professor Gareth Veal Professor Andrew Pearson Dr Chris Redfern	Retinoid X receptors and retinoid response in neuroblastoma cells	2002
Dr Emma Meczes Professor Andrew Pearson Professor Caroline Austin Dr Michael Tilby	Schedule-dependent response of neuroblastoma cell lines to combinations of etoposide and cisplatin	2002
Professor Andrew Pearson	Temozolomide in malignant gliomas of childhood : a United Kingdom Children's Cancer Study Group and French Society for Paediatric Oncology Intergroup Study.	2002
Dr Paul Griffiths Professor Andrew Pearson	Temozolomide in malignant gliomas of childhood: A United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup study	2002
Alice Burns Dr Evelyn Jaros Mike Cole Emeritus Professor Robert Perry Professor Andrew Pearson et al.	The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system	2002
Professor Gareth Veal Melanie Griffin Annie Parry Dr Juliet Hale Professor Andrew Pearson et al.	A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin	2001
Professor Herbie Newell Professor Alan Boddy Geoffrey Taylor Andrew Johnston Professor Andrew Pearson et al.	A phase I study of nolatrexed dihydrochloride in children with advanced cancer. A United Kingdom Children's Cancer Study Group Investigation	2001
Professor Andrew Pearson	Advances in Neuroblastoma Research 1998 - Introduction	2001
Professor Penny Lovat Dr Chris Redfern Professor Andrew Pearson	Apoptosis in neuroblastomas induced by interferon-gamma involves the CD95/CD95L pathway	2001
Dr Emma Meczes Professor Andrew Pearson Dr Michael Tilby	Characterisation of the DNA damage recognised by a monoclonal antibody raised against cisplatin-modified DNA	2001
Professor Andrew Pearson	Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year	2001
Dr Richard Gilbertson Roberto Hernan Emeritus Professor Robert Perry Professor John Lunec Professor Andrew Pearson et al.	Clinical and molecular stratification of disease risk in medulloblastoma	2001
Dr Maria Lastowska Simon Cotterill Dr Nicholas Bown Dr Katia Mazzocco Professor Andrew Pearson et al.	Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors	2001
Mike Cole Professor Andrew Pearson Professor Alan Boddy	Cyclophosphamide metabolism in children following a 1-h and a 24-h infusion	2001
Professor Penny Lovat Dr Mark Dobson Professor Archibald Malcolm Professor Andrew Pearson Dr Chris Redfern et al.	Differential gene regulation by 9-cis and all-trans retinoic acid in neuroblastoma cells	2001
Professor Deborah Tweddle Professor Archibald Malcolm Dr Nicholas Bown Professor Andrew Pearson Professor John Lunec et al.	Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line	2001
Dr Debbie Scott Professor Andrew Pearson Professor John Lunec	Identification of novel coding exons within the neuroblastoma amplified gene, NAG.	2001
Professor Gareth Veal Dr Cinera Dias Annie Parry Julie Errington Dr Juliet Hale et al.	Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy	2001
Professor Gareth Veal Julie Errington Dr Chris Redfern Professor Andrew Pearson Professor Alan Boddy et al.	Influence of retinoid isomerisation on the cellular activity of 13-cis retinoic acid in neuroblastoma	2001
Professor Andrew Pearson	Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM	2001
Joanna Elsden Dr Rebecca Kenyon Professor Andrew Pearson Professor John Lunec	Is DDX1 an oncogene? How does its pattern of expression relate to its amplification status?	2001
Simon Cotterill Professor Andrew Pearson Dr Jeanette Pritchard	Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: A report from the European Neuroblastoma Study Group "Survey"	2001
Dr Maria Lastowska Dr Nicholas Bown Professor John Lunec Professor Tom Strachan Professor Andrew Pearson et al.	Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma	2001
Dr Maria Lastowska Dr Nicholas Bown Professor John Lunec Professor Tom Strachan Professor Andrew Pearson et al.	Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma	2001
Dr Maria Lastowska Dr Nicholas Bown Professor Andrew Pearson	Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?	2001
Dr Richard Gilbertson Roberto Hernan Professor David Ellison Emeritus Professor Robert Perry Professor Andrew Pearson et al.	Novel ErbB4 juxtamembrane splice variants and the truncated ErbB2 receptor isoform are frequently expressed in childhood medulloblastoma	2001
Dr Richard Gilbertson Roberto Hernan Professor David Ellison Emeritus Professor Robert Perry Professor Andrew Pearson et al.	Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma	2001
Professor Deborah Tweddle Mike Cole Professor Andrew Pearson	OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age	2001
Professor Deborah Tweddle Professor Archibald Malcolm Mike Cole Professor Andrew Pearson Professor John Lunec et al.	p53 cellular localization and function in neuroblastoma: evidence for defective G1 arrest despite WAF1 induction in MYCN-amplified cells	2001
Dr Pamela Kearns Professor Andrew Pearson Dr Andrew Hall	Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia	2001
Simon Cotterill Professor John Lunec Professor Andrew Pearson	Relationship between histopathological features, MYCN amplification, and prognosis: A UKCCSG study	2001
Dr Birju Rana Professor Andrew Pearson Dr Chris Redfern	RXRβ isoforms in neuroblastoma cells and evidence for a novel 3′-end transcript	2001
Professor Simon Bailey Dr Andrew Hall Professor Andrew Pearson Dr Chris Redfern	The role of AP-1 in glucocorticoid resistance in leukaemia	2001
Dr Sally Coulthard Dr Christopher Howell Lynne Minto Dr Peter Middleton Professor Graham Jackson et al.	A comparison of molecular and enzyme-based assays for the detection of thiopurine methyltransferase mutations	2000
Dr Kay Padget Professor Andrew Pearson Dr Michael Tilby Professor Caroline Austin	Camptothecin-stabilised topoisomerase I-DNA complexes in leukaemia cells visualised and quantified in situ by the TARDIS assay (trapped in agarose DNA immunostaining)	2000
Simon Cotterill Professor Andrew Pearson	Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992	2000
Professor Andrew Pearson Emeritus Professor Robert Perry Professor John Lunec	Detection of amplified and transcribed sequences at the chromosome 12q13-15 locus in NGP neuroblastoma cells by Alu-PCR	2000
Professor Penny Lovat Dr Michael Tilby Professor Archibald Malcolm Professor Andrew Pearson Dr Chris Redfern et al.	Distinct properties of fenretinide and CD437 lead to synergistic responses with chemotherapeutic reagents	2000
Professor Penny Lovat Professor Archibald Malcolm Professor Andrew Pearson Dr Chris Redfern	Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma	2000
Dr Nicholas Bown Professor John Lunec Professor Archibald Malcolm Professor Andrew Pearson	Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma	2000
Professor Gareth Veal Dr Cinera Dias Professor Alan Boddy Annie Parry Dr Juliet Hale et al.	In vitro/in vivo correlations of cisplatin-DNA adduct levels in leucocytes of children	2000
Simon Cotterill Professor Andrew Pearson	Phase I trials in pediatric oncology: Perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group	2000
Huw Thomas Professor Alan Boddy Professor Andrew Pearson Professor Herbie Newell	Prospective validation of renal function-based carboplatin dosing in children with cancer: A United Kingdom Children's Cancer Study Group Trial	2000
Dr Kay Padget Professor Andrew Pearson Professor Caroline Austin	Quantitation of DNA topoisomerase II alpha and beta in human leukaemia cells by immunoblotting	2000
Dr Kay Padget Professor Andrew Pearson Professor Caroline Austin	Quantitation of DNA topoisomerase IIalpha and beta in human leukaemia cells by immunoblotting	2000
Dr Quentin Campbell Hewson Professor Penny Lovat Professor Archibald Malcolm Professor Andrew Pearson Dr Chris Redfern et al.	Receptor mechanisms mediating differentiation and proliferation effects of retinoids on neuroblastoma cells	2000
Professor Penny Lovat Dr Michael Tilby Professor Archibald Malcolm Professor Andrew Pearson Dr Chris Redfern et al.	Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs	2000
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman Emeritus Professor Alan Craft Dr Juliet Hale Dr Jennifer Kernahan et al.	The United Kingdom Childhood Cancer Study: objectives, materials and methods	2000
Mike Cole Professor Andrew Pearson Professor Alan Boddy	Cyclophosphamide metabolism in children with Fanconi's anaemia	1999
Dr Pamela Kearns Dr Andrew Hall Professor Andrew Pearson	Different expression of glutathione S-transferase α, µ and π in childhood acute lymphoblastic and myeloid leukaemia	1999
Professor Penny Lovat Dr Mark Dobson Professor Archibald Malcolm Professor Andrew Pearson Dr Chris Redfern et al.	Differential effects of retinoic acid isomers on the expression of nuclear receptor co-regulators in neuroblastoma	1999
Professor Roderick Skinner Professor Andrew Pearson Emeritus Professor Alan Craft	Dose-related nephrotoxicity of carboplatin in children	1999
Dr Richard Gilbertson Roberto Hernan Professor Andrew Pearson Professor John Lunec	Expression and characterisation of novel ErbB-4 alternative spliced variants by childhood	1999
Dr Nicholas Bown Simon Cotterill Dr Maria Lastowska Dr Seamus O'Neill Professor Andrew Pearson et al.	Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma	1999
Professor Simon Bailey Dr Andrew Hall Professor Andrew Pearson Dr Michael Reid Dr Chris Redfern et al.	Glucocorticoid resistance and the AP-1 transcription factor in leukaemia	1999
Dr Pamela Kearns Professor Andrew Pearson Dr Andrew Hall	Glutathione in childhood acute leukaemias	1999
Gordon Taylor Professor John Lunec Professor Andrew Pearson Professor Herbie Newell	Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines	1999
Professor Gareth Veal Professor Alan Boddy Huw Thomas Annie Parry Professor Andrew Pearson et al.	Real-time monitoring of carboplatin pharmacokinetics in paediatric patients receiving high dose chemotherapy	1999
Dr Emma Meczes Professor Caroline Austin Professor Andrew Pearson Dr Michael Tilby	Synergy studies of etoposide and cisplatin action in neuroblastoma cell lines	1999
Mike Cole Emerita Professor Suzanne Cholerton Professor Ann Daly Professor Andrew Pearson Professor Alan Boddy et al.	The effect of fluconazole on cyclophosphamide metabolism in children	1999
Dr Richard Gilbertson Roberto Hernan Professor Andrew Pearson Professor John Lunec	The ErbB2 receptor represents a potential target for novel therapies in childhood medulloblastoma.	1999
Professor Andrew Pearson Professor Herbie Newell Mike Cole	A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in children	1998
Professor Roderick Skinner Dr Andrew Hall Professor Andrew Pearson	Acute changes in urine protein excretion may predict chronic ifosfamide nephrotoxicity: a preliminary observation	1998
Professor Penny Lovat Dr Chris Redfern Professor Andrew Pearson	Apoptosis in neuroblastomas induced by interferon-γ involves the CD95/CD95L pathway	1998
Professor Roderick Skinner Professor Andrew Pearson Dr Malcolm Coulthard Emeritus Professor Alan Craft	Cisplatin dose rate as a risk factor for nephrotoxicity in children	1998
Mike Cole Professor Andrew Pearson Professor Alan Boddy	Cyclophosphamide metabolism in children with Fanconi's anaemia	1998
Gordon Taylor Professor Herbie Newell Professor Alan Boddy Andrew Johnston Professor Andrew Pearson et al.	Deoxyuridine plasma levels during the phase I study of nolatrexed in children with advanced cancer	1998
Professor Penny Lovat Dr Mark Dobson Professor Archibald Malcolm Professor Andrew Pearson Dr Chris Redfern et al.	Differential gene regulation by 9-cis and all-trans retinoic acid in neuroblastoma cells	1998
Professor Deborah Tweddle Professor Andrew Pearson Professor Archibald Malcolm Professor John Lunec	Does TP53 function in neuroblastoma?	1998
Alice Burns Dr Evelyn Jaros Professor Andrew Pearson Emeritus Professor Robert Perry Professor John Lunec et al.	Expression of p53, Waf-1, Bcl-2, and Bax in central primitive neuroectodermal tumours (cPNET)	1998
Dr Richard Gilbertson Professor Steven Clifford Dr Christopher Wright Emeritus Professor Robert Perry Professor Andrew Pearson et al.	Expression of the ErbB-neuregulin signaling network during human cerebellar development: Implications for the biology of medulloblastoma	1998
Dr Pamela Kearns Professor Andrew Pearson Dr Andrew Hall	Glutathione levels in leukaemic blasts	1998
Dr Maria Lastowska Dr Nicholas Bown Professor John Lunec Professor Tom Strachan Professor Andrew Pearson et al.	Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines	1998
Simon Cotterill Professor John Lunec Professor Andrew Pearson	Neuroblastoma cells provoke Schwann cell proliferation in vitro	1998
Professor Alan Boddy Melanie Griffin Dr Margaret Little Professor Andrew Pearson	Pharmacokinetics and blood distribution in paediatric patients of SPI-77: Cisplatin encapsulated in Stealth® liposomes	1998
Dr Anil Gholkar OBE Professor Herbie Newell Professor Andrew Pearson	Phase I study of temozolomide in paediatric patients with advanced cancer	1998
Professor Penny Lovat Dr Quentin Campbell Hewson Professor Archibald Malcolm Professor Andrew Pearson Dr Chris Redfern et al.	Retinoid-induced differentiation of neuroblastoma: Comparison between LG69, an RXR-selective analogue and 9-cis retinoic acid	1998
Dr Andrew Hall Professor John Lunec Professor Herbie Newell Professor Andrew Pearson Geoffrey Taylor et al.	Thymidylate synthase expression in nolatrexed and methotrexate-resistant human leukaemia cell lines	1998
Professor Deborah Tweddle Professor Archibald Malcolm Dr Michael Reid Mike Cole Professor John Lunec et al.	TP53 and related protein expression in primary and metastatic neuroblastoma	1998
Huw Thomas Professor Alan Boddy Professor Andrew Pearson Professor Herbie Newell	Validation of pharmacologically-guided dosing of carboplatin in paediatric patients	1998
Professor Penny Lovat Professor Archibald Malcolm Professor Andrew Pearson Dr Chris Redfern	9-cis retinoic acid - A better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma	1997
Dr Rebecca Kenyon Professor Andrew Pearson Professor John Lunec	Analysis of candidate gene co-amplification with MYCN in neuroblastoma	1997
Professor Penny Lovat Professor Archibald Malcolm Professor Andrew Pearson Dr Chris Redfern	Apoptosis of N-type neuroblastoma cells after differentiation with 9- cis-retinoic acid and subsequent washout	1997
Professor Alan Boddy Professor Andrew Pearson Dr Michael Tilby Professor Herbie Newell	Cisplatin pharmacokinetics in children with cancer	1997
Professor Andrew Pearson Professor Alan Boddy	Cyclophosphamide and ifosfamide metabolites in the cerebrospinal fluid of children	1997
Simon Cotterill Professor Andrew Pearson Dr Nicholas Bown	Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients	1997
Professor Roderick Skinner Emeritus Professor Alan Craft Professor Andrew Pearson	Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child	1997
Dr Richard Gilbertson Dr Evelyn Jaros Emeritus Professor Robert Perry Professor John Lunec Professor Andrew Pearson et al.	Mitotic percentage index: A new prognostic factor for childhood medulloblastoma	1997
Dr Michael Tilby Professor Andrew Pearson Professor Alan Boddy Professor Herbie Newell	Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy	1997
Dr Richard Gilbertson Emeritus Professor Robert Perry Professor Andrew Pearson Professor John Lunec	Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma	1997
Dr Maria Lastowska Professor Andrew Pearson Dr John Wolstenholme Dr Nicholas Bown	Promiscuous translocations of chromosome arm 17q in human neuroblastomas	1997
Professor Penny Lovat Professor Archibald Malcolm Professor Andrew Pearson Dr Chris Redfern	Retinoids in neuroblastoma therapy: Distinct biological properties of 9- cis- and all-trans-retinoic acid	1997
Dr Richard Gilbertson Dr Evelyn Jaros Professor John Lunec Professor Andrew Pearson	The epidermal growth factor receptor (EGFR) family and childhood medulloblastoma	1997
Professor Roderick Skinner Professor Andrew Pearson Emeritus Professor Alan Craft	The influence of ifosfamide scheduling on acute nephrotoxicity in children	1997
Professor Alan Calvert Dr Andrew Hall Professor John Lunec Professor Herbie Newell Professor Andrew Pearson et al.	The relationship between intrinsic thymidylate synthase expression and sensitivity to THYMITAQ® in human leukaemia and colorectal carcinoma cell lines	1997
Professor Alan Boddy Mike Cole Professor Andrew Pearson	Cyclophosphamide pharmacokinetics in children	1996
Professor Andrew Pearson	Future directions in the pharmacology of anti-cancer agents in children	1996
Professor Alan Boddy Professor Andrew Pearson Professor Roderick Skinner	Ifosfamide nephrotoxicity: Limited influence of metabolism and mode of administration during repeated therapy in paediatrics	1996
Professor Alan Boddy Professor Andrew Pearson	Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administration	1996
Professor Alan Boddy Professor Andrew Pearson	Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administration	1996
Dr Rebecca Kenyon Professor Archibald Malcolm Professor Andrew Pearson Professor John Lunec	Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma	1996
Professor Alan Boddy Professor Herbie Newell Professor Andrew Pearson	Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis	1996
Professor Herbie Newell Professor Andrew Pearson	Phase I trials in paediatric oncology - The European perspective - On behalf of the new agents group of the United Kingdom Childrens Cancer Study Group	1996
Professor Simon Bailey Professor Roderick Skinner Dr Helen Lucraft Emeritus Professor Robert Perry Nicholas Todd et al.	Pineal tumours in the north of England 1968-93	1996
Professor Alan Boddy Professor Andrew Pearson Professor Herbie Newell	Population pharmacokinetics of carboplatin in children	1996
Professor Roderick Skinner Professor Andrew Pearson Dr Malcolm Coulthard Emeritus Professor Alan Craft	Risk factors for ifosfamide nephrotoxicity in children	1996
Professor Roderick Skinner Mike Cole Professor Andrew Pearson Dr Malcolm Coulthard Emeritus Professor Alan Craft et al.	Specificity of pH and osmolality of early morning urine sample in assessing distal renal tubular function in children: Results in healthy children	1996
Dr Kevin Windebank Dr Michael Lowry Professor Andrew Pearson	Successful treatment of non-familial haemophagocytic lymphohistiocytosis with interferon and gammaglobulin	1996
Dr Linda Hogarth Professor Andrew Pearson Dr Andrew Hall	The effect of treatment with high dose melphalan, cisplatin or carboplatin on levels of glutathione in plasma, erythrocytes, mononuclear cells and urine	1996
Professor Andrew Pearson Emeritus Professor Alan Craft Dr Jennifer Kernahan Professor Kim Bartlett	Whole body protein metabolism in children with cancer	1996
Professor Alan Boddy Professor Andrew Pearson	Comparison of continuous infusion and bolus administration of ifosfamide in children	1995
Professor Alan Boddy Mike Cole Professor Andrew Pearson Professor Herbie Newell	Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients	1995
Professor Alan Boddy Mike Cole Professor Andrew Pearson	Cyclophosphamide Metabolism in Children	1995
Professor Andrew Pearson	Decline in incidence of medulloblastoma in children - reply	1995
Professor Herbie Newell Professor Andrew Pearson	Exposure and schedule dependency of etoposide in neuroblastoma and leukaemia cells in vitro	1995
Dr Chris Redfern Professor Penny Lovat Professor Archibald Malcolm Professor Andrew Pearson	Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid	1995
Professor Andrew Pearson	Genetics, Cellular Biology and Clinical Management of Human Neuroblastoma: Preface	1995
Professor Andrew Pearson Professor Archibald Malcolm Professor Stephen Proctor Dr Peter Hamilton Professor Andrew Cant et al.	Human herpes virus-6 infection in marrow graft recipients: Role in pathogenesis of graft-versus-host disease	1995
Dr Richard Gilbertson Professor Andrew Pearson Emeritus Professor Robert Perry Dr Evelyn Jaros	Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma	1995
Professor Andrew Pearson Professor Stephen Proctor Dr Peter Hamilton Professor Andrew Cant Professor Archibald Malcolm et al.	Role of target organ infection with cytomegalovirus in the pathogenesis of graft-versus-host disease	1995
Dr Nicholas Bown Professor Archibald Malcolm Dr Michael Reid Professor Andrew Pearson	Solid alveolar rhabdomyosarcoma with a t(2;13)	1995
Professor Alan Boddy Mike Cole Professor Andrew Pearson	The kinetics of the auto-induction of ifosfamide metabolism during continuous infusion	1995
Dr Stephen Pedler Emeritus Professor Alan Craft Dr Jennifer Kernahan Dr Kevin Windebank Professor Andrew Pearson et al.	Changing causes if septicemia in paediatric oncology patients: effect of imipenem use	1994
Professor Penny Lovat Professor Andrew Pearson Professor Archibald Malcolm Dr Chris Redfern	Concentration-dependent effects of 9-cis retinoic acid on neuroblastoma differentiation and proliferation in vitro	1994
Dr Nicholas Bown Dr Michael Reid Professor Archibald Malcolm Emeritus Professor Alan Craft Professor Andrew Pearson et al.	Cytogenic abnormalities of small round-cell tumors	1994
Professor Andrew Pearson	Decline in incidence of medulloblastoma in children	1994
Professor Andrew Pearson Dr Judith Wilkes Professor Archibald Malcolm	Diagnostic features of transfusion associated graft versus host disease	1994
Dr Chris Redfern Professor Penny Lovat Professor Archibald Malcolm Professor Andrew Pearson	Differential effects of 9-cis and all-trans retinoic acid on the induction of retinoic acid receptor-beta and cellular retinoic acid-binding protein II in human neuroblastoma cells	1994
Dr Andrew Mellon David Talbot Professor Andrew Pearson	Duodenal leiomyosarcoma presenting with iron deficiency anemia	1994
Dr Andrew Hall Professor Andrew Pearson Professor Archibald Malcolm Dr Michael Reid	Glutathione S-transferase in bone marrow metastases of disseminated neuroblastoma	1994
Professor Alan Boddy Emerita Professor Suzanne Cholerton Professor Ann Daly Professor Andrew Pearson	Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide	1994
Professor Roderick Skinner Professor Andrew Pearson Emeritus Professor Alan Craft	Ifosfamide nephrotoxicity in children	1994
Professor Andrew Pearson Emeritus Professor Alan Craft	Ifosfamide-induced hyperpigmentation	1994
Professor Roderick Skinner Mike Cole Professor Andrew Pearson Dr Michael Keir Dr Malcolm Coulthard et al.	Inaccuracy of glomerular-filtration rate estimation from height/plasma creatinine ratio	1994
Professor Andrew Pearson Professor Archibald Malcolm	Late development of graft-versus-host disease in an autologous BMT recipient	1994
Dr Peter Dawes Professor Archibald Malcolm Professor Andrew Pearson	Occurrence of seminoma and dysgerminoma in father and daughter	1994
Professor Andrew Pearson	Potential inhibition of alkylating agent metabolism by fluconazole	1994
Dr Nicholas Bown Dr Michael Reid Professor Archibald Malcolm Professor Andrew Pearson	Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smears. United Kingdom Children's Cancer Study Group	1994
Professor Andrew Pearson Jerome Evans Dr Michael Reid	Secondary chronic myelomonocytic leukemia with t(9;11) in a child	1994
Professor Alan Boddy Professor Andrew Pearson Dr Michael Tilby Professor Herbie Newell	The comparative pharmacokinetics and pharmacodynamics of cisplatin and carboplatin in pediatric patients: A review.	1994
Dr Michael Reid Professor Andrew Pearson Professor Stephen Proctor Dr Peter Hamilton Dr Andrew Hall et al.	The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia	1994
Professor Andrew Pearson John Emslie Dr Anne Lennard Emeritus Professor Robert Perry Peter Crawford et al.	Cytogenetic abnormalities in a disseminated medulloblastoma	1993
Dr Evelyn Jaros Professor John Lunec Emeritus Professor Robert Perry Professor Andrew Pearson	P53 Protein Overexpression Identifies a Group of Central Primitive Neuroectodermal Tumors with Poor Prognosis	1993
Professor Andrew Pearson	21-day schedule oral etoposide in children--a feasibility study	1993
Dr Michael Laker Professor Andrew Pearson	Analysis of multiple sugar probes in urine and plasma by high performance anion exchange chromatography with pulsed electrochemical detection - application in the assessment of intestinal permeability in Human Imuno Deficiency Virus infection	1993
Professor Herbie Newell Professor Andrew Pearson Dr Michael Keir Professor Alan Calvert	Carboplatin Pharmacokinetics in Children - the Development of a Pediatric Dosing Formula	1993
Professor Andrew Pearson	Effect of nutritional status on the incidence of infection in childhood cancer	1993
Professor Andrew Pearson Professor Herbie Newell Mike Cole	Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation	1993
Dr Nicholas Bown Professor Andrew Pearson Dr Michael Reid	High incidence of constitutional balanced translocations in neuroblastoma	1993
Professor Roderick Skinner Dr Ian Sharkey Professor Andrew Pearson Emeritus Professor Alan Craft	Ifosfamide, mesna, and nephrotoxicity in children	1993
Professor Andrew Pearson Dr Jennifer Kernahan Dr Helen Lucraft Anne Thompson Emeritus Professor Alan Craft et al.	Low dose continuous infusion doxorubicin in children and young adults	1993
Professor Alan Boddy Professor Andrew Pearson	Pharmacokinetics and Metabolism of Ifosfamide Administered as a Continuous Infusion in Children	1993
Professor Andrew Pearson Dr Peter Hamilton Professor Stephen Proctor Professor Archibald Malcolm	Prognostic importance of histological and immunopathological assessment of skin and rectal biopsies in patients with GVHD	1993
Professor Andrew Pearson Dr Michael Reid Emeritus Professor Alan Craft	Prohibitive toxicity of a dose intense regime for metastatic neuroblastoma containing ifosfamide, doxorubicin and cisplatin	1993
Professor Andrew Pearson Professor Alan Boddy	Reproducibility of Methods Relating to Cyclophosphamide Metabolic Studies; response	1993
Professor Penny Lovat Professor Andrew Pearson Professor Archibald Malcolm Dr Chris Redfern	Retinoic acid receptor expression during the in vitro differentiation of human neuroblastoma	1993
Dr Richard Lee Professor Andrew Pearson	Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment	1993
Dr Michael Laker Professor Andrew Pearson	Simultaneous quantification of mannitol, 3-O-methyl glucose, and lactulose in urine by HPLC with pulsed electrochemical detection, for use in studies of intestinal permeability	1993
Professor Andrew Pearson Professor Archibald Malcolm	The need for endoscopic biopsy in the diagnosis of upper gastrointestinal graft-versus-host disease	1993
Professor Andrew Pearson Dr Michael Reid Emeritus Professor Alan Craft	Treatment of advanced neuroblastoma	1993
Alan Rich Professor Andrew Pearson Emeritus Professor Alan Craft Dr Jennifer Kernahan	Comparison of saphenous versus jugular veins for central venous access in children with malignancy	1992
Professor Andrew Pearson Dr Robert Nelson	Gut hormones and gastrointestinal motility in children with cystic fibrosis	1992
Professor Andrew Pearson Emeritus Professor Alan Craft Dr Michael Reid	High-dose rapid schedule chemotherapy for disseminated neuroblastoma	1992
Claire Taylor Professor Andrew Pearson Professor Archibald Malcolm	Human herpes virus 6 and endogenous biotin in salivary glands	1992
Professor Andrew Pearson Dr Susan Hudson Dr Robin Bray Dr John Beesley	Necrobacillosis with pancytopenia	1992
Professor Alan Boddy Professor Andrew Pearson	Pharmacokinetics and metabolism of cyclophosphamide in paediatric patients	1992
Dr Richard Gilbertson Dr Evelyn Jaros Emeritus Professor Robert Perry Professor Andrew Pearson	Prognostic factors in medulloblastoma	1992
Dr Evelyn Jaros Emeritus Professor Robert Perry Peter Crawford Emeritus Professor David Mendelow Professor Andrew Pearson et al.	Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours	1992
Dr Alistair Gascoigne Dr Judith Wilkes Professor Andrew Pearson Professor Archibald Malcolm	The immunohistopathology of obliterative bronchiolitis following lung transplantation	1992
Professor Roderick Skinner Professor Andrew Pearson Dr Malcolm Coulthard Emeritus Professor Alan Craft	The influence of age on nephrotoxicity following chemotherapy in children	1992
Claire Taylor Professor Andrew Pearson Professor Archibald Malcolm	The potential value of the polymerase chain reaction (PCR) in the management of bone marrow transplant patients	1992
Professor Andrew Pearson Dr Michael Reid Emeritus Professor Alan Craft	Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma	1992
Professor Roderick Skinner Professor Andrew Pearson Dr Malcolm Coulthard Dr Andrew Skillen Dr UNKNOWN Gibb et al.	Assessment of chemotherapy-associated nephrotoxicity in children with cancer	1991
Professor Andrew Pearson Professor Archibald Malcolm	Augmentation of graft versus host disease (GVHD) by cytomegalovirus (CMV) infection	1991
Dr Michael Reid Professor Andrew Pearson	Bone-marrow infiltration in neuroblastoma	1991
Professor Andrew Pearson Emeritus Professor Alan Craft	Choroidal involvement in lymphomatoid granulomatosis	1991
Professor Archibald Malcolm Professor Andrew Pearson Emeritus Professor Alan Craft	Cytogenetic analysis of a congenital fibrosarcoma	1991
Alan Rich Professor Andrew Pearson	Displacement of central venous catheters - an observation	1991
Dr Michael Reid Dr Jonathan Wallis Professor Andrew Pearson Professor Archibald Malcolm	Routine histological compared with immunohistological examination of bone marrow trephine biopsy specimens in disseminated neuroblastoma	1991
Professor Andrew Pearson Professor Archibald Malcolm	The effect of interferon gamma on a colonic epithelial cell line	1991
Dr Alistair Gascoigne Dr Judith Wilkes Professor Andrew Pearson Professor Archibald Malcolm	The immunohistological features of obliterative bronchiolitis following lung transplantation	1991
Professor Andrew Pearson Emeritus Professor Alan Craft	The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia	1991
Professor Andrew Pearson Dr Ian Sharkey Emeritus Professor Alan Craft	Urinary retention--an unusual dystonic reaction to continuous metoclopramide infusion	1991
Professor Anne Dickinson Dr Peter Carey Professor Andrew Pearson Professor Stephen Proctor	An in vitro predictive test for clinical graft-versus-host disease in allogeneic bone marrow transplant recipients	1990
Professor Roderick Skinner Professor Andrew Pearson Dr Malcolm Coulthard Emeritus Professor Alan Craft	Nephrotoxicity after ifosfamide	1990
Professor Roderick Skinner Professor Andrew Pearson David Mathias Emeritus Professor Alan Craft	Ototoxicity of cisplatinum in children and adolescents	1990
Dr Jeanette Pritchard Professor Andrew Pearson	Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group	1990
Professor Andrew Pearson Dr Michael Laker	The effect of pharmacological modification of gastric emptying and mouth-to-caecum transit time on the absorption of sugar probe marker molecules of intestinal permeability in normal man	1990
Professor Andrew Pearson Dr Michael Reid Dr Jennifer Kernahan Emeritus Professor Alan Craft Dr Peter Hamilton et al.	Virus infections in bone marrow transplant recipients: a three year prospective study	1990
Sue Thompson Professor Andrew Pearson	A preliminary study of serum class II levels in healthy individuals and bone-marrow transplant patients	1989
Professor Andrew Pearson Dr Mike Laker Dr Robert Nelson	Active and passive sugar absorption in pancreatic insufficiency	1989
Professor Andrew Pearson John Emslie Dr Michael Reid Professor Archibald Malcolm Emeritus Professor Alan Craft et al.	Chromosome 22 abnormalities in Ewing's sarcoma	1989
Dr Nicholas Bown Professor Andrew Pearson Dr Michael Reid	Cytogenetic studies of childhood solid tumors	1989
Dr Nicholas Bown Professor Andrew Pearson Dr Michael Reid	Cytogenetic studies of pediatric solid tumors	1989
Professor Andrew Pearson Professor Archibald Malcolm Professor Stephen Proctor Dr Peter Hamilton	Expression of MHC class I and II antigens by keratinocytes and enterocytes in acute graft-versus-host disease	1989
Professor Roderick Skinner Professor Andrew Pearson Emeritus Professor Alan Craft	Hypophosphataemic rickets after ifosfamide treatment in children	1989
Professor Archibald Malcolm Professor Andrew Pearson	Improved method for immunoperoxidase detection of membrane antigens in frozen sections	1989
Dr Robert Nelson Professor Andrew Pearson Dr Mike Laker	Intestinal permeability in Crohn's disease	1989
Professor Andrew Pearson Dr Michael Laker Emeritus Professor Alan Craft	Intestinal permeability tests and integrity of the small intestinal mucosa	1989
Professor Roderick Skinner Professor Andrew Pearson Dr Malcolm Coulthard Emeritus Professor Alan Craft	Nephrotoxicity of ifosfamide in children	1989
Emeritus Professor Alan Craft Professor Andrew Pearson	Three decades of chemotherapy for childhood cancer: from 'cure at any cost' to 'cure at least cost'	1989
Professor Andrew Pearson Dr Peter Hamilton Professor Stephen Proctor Professor Archibald Malcolm	Class II antigen expression by keratinocytes and enterocytes: An early feature of graft-versus-host-disease	1988
Professor Andrew Pearson Emeritus Professor Alan Craft Dr Stephen Pedler	Clostridium difficile in an oncology unit	1988
Dr Nicholas Bown Professor Andrew Pearson Professor Archibald Malcolm	Cytogenetic abnormalities in a primitive neuroectodermal tumor	1988
Professor Andrew Pearson Dr Michael Reid Dr Nicholas Bown Professor Archibald Malcolm Emeritus Professor Alan Craft et al.	Cytogenetic investigations of solid tumours of children	1988
Professor Andrew Pearson Emeritus Professor Alan Craft	Globe luxation in histiocytosis X	1988
Professor Andrew Pearson Dr Michael Laker Emeritus Professor Alan Craft	Gut damage during the treatment of childhood acute lymphoblastic leukemia	1988
Professor Andrew Pearson	Health education: patients' perception	1988
Professor Andrew Pearson Dr Peter Hamilton Professor Stephen Proctor Professor Archibald Malcolm	Histological features of skin and rectal biopsy specimens after autologous and allogeneic bone marrow transplantation	1988
Professor Andrew Pearson Professor Archibald Malcolm	HLA-DR, DP and DQ expression in graft versus host disease (GVHD)	1988
Professor Andrew Pearson Professor Archibald Malcolm	HLA-DR, DP and DQ expression in graft versus host disease (GVHD)	1988
Dr Peter Carey Dr Michael Reid Dr Peter Hamilton Professor Andrew Pearson Professor Stephen Proctor et al.	HLA-DR, DP and DQ expression in GRAFT versus host disease (GVHD)	1988
Dr Peter Carey Professor Archibald Malcolm Professor Andrew Pearson Dr Michael Reid	Immunocytochemical detection of tumours of neuroectodermal origin	1988
Professor Archibald Malcolm Professor Andrew Pearson	Improved sensitivity for the immunoperoxidase technique	1988
Professor Andrew Pearson Emeritus Professor Alan Craft Dr Michael Laker	Intestinal permeability during chemotherapy for childhood tumours	1988
Professor Andrew Pearson Professor Stephen Proctor Dr Peter Hamilton Professor Archibald Malcolm	Lymphocyte subpopulation in early graft versus host disease (GVHD)	1988
Dr Nicholas Bown Professor Andrew Pearson Peter Crawford Emeritus Professor Robert Perry	Multiple chromosome rearrangements in a childhood ependymoma	1988
Professor Roderick Skinner Professor Andrew Pearson David Mathias Emeritus Professor Alan Craft	Ototoxicity of cis-platinum	1988
Professor Anne Dickinson Dr Peter Carey Dr Michael Reid Dr Peter Hamilton Professor Andrew Pearson et al.	Skin explant culture as a model for graft versus host disease	1988
Dr Stephen Thompson Professor Andrew Pearson	The possible use of serum MHC class-II levels for monitoring GRAFT-versus-host disease in bone marrow transplant recipients	1988
Professor Andrew Pearson Emeritus Professor Alan Craft	Ultra high dose induction regime for disseminated neuro-blastoma - napoleon	1988
Professor Andrew Pearson Dr Michael Reid Emeritus Professor Alan Craft	Chromosomes of metastatic retinoblastoma	1987
Professor Andrew Pearson Professor Archibald Malcolm	Class II antigen (HLA-DR) expression on epidermal keratinocytes and colonic epithelial cells is an early occurrence in acute graft versus host disease (GVHD)	1987
Dr Nicholas Bown Dr Michael Reid Professor Andrew Pearson Professor Archibald Malcolm Emeritus Professor Alan Craft et al.	Cytogenic investigations in the assessment of response to treatment in neuroblastoma	1987
Professor Andrew Pearson Professor Archibald Malcolm	Early immunopathological changes in the target organs of graft versus host disease (GVHD)	1987
Professor Andrew Pearson Emeritus Professor Alan Craft	Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia	1987
Professor Andrew Pearson Emeritus Professor Alan Craft	Tetany in children treated with cisplatinum	1987
Professor Andrew Pearson	Bone marrow transplantation for glycogen storage disease type II (Pompé's disease)	1986
Professor Andrew Pearson Professor Archibald Malcolm	Histological features of graft versus host disease (GVHD) in autologous and allogeneic bone marrow transplant (BMT) recipients	1986
Professor Andrew Pearson Emeritus Professor Alan Craft	Small intestinal transit time affects methotrexate absorption in children with acute lymphoblastic leukemia	1985
Professor Andrew Pearson Emeritus Professor Alan Craft Dr Michael Laker	Small bowel function in acute lymphoblastic leukaemia	1984
Emeritus Professor Alan Craft Elizabeth Nicholson Professor Andrew Pearson	Dystonic reactions and the pharmacokinetics of metoclopramide in children	1983
Professor Andrew Pearson Emeritus Professor Alan Craft Emeritus Professor Robert Perry	Four primary tumors in one child	1983
Professor Andrew Pearson Dr Victor McAllister	Intracranial calcification in survivors of childhood medulloblastoma	1983
Professor Andrew Pearson Dr Hugh Bain Emeritus Professor Alan Craft	Lymphomatoid granulomatosis in a 10 year old boy	1983
Professor Andrew Pearson Dr Michael Laker Dr Robert Nelson	The gluten challenge: biopsy v permeability	1983
Professor Andrew Pearson Dr Michael Laker Emeritus Professor Alan Craft Dr Robert Nelson	Intestinal permeability in children with Crohns disease and celiac disease	1982
Professor Andrew Pearson Dr Michael Laker Dr Robert Nelson	INTESTINAL PERMEABILITY IN CROHNS-DISEASE	1982
Professor Andrew Pearson Emeritus Professor Alan Craft	Two families with the Li-Fraumeni cancer family syndrome	1982